Standardized Herbal PM014 Formula Ameliorates Pulmonary Fibrosis in COVID-19 Patients by Inhibiting the TGF-β1 Signaling Pathway

Maryam Allahverdi-Khani; Luis Ulloa; Majid Motaghinejad; Mahsa Salehirad

doi:10.30699/jambs.30.140.211

Standardized Herbal PM014 Formula Ameliorates Pulmonary Fibrosis in COVID-19 Patients by Inhibiting the TGF-β1 Signaling Pathway

Maryam Allahverdi-Khani, Luis Ulloa, Majid Motaghinejad, Mahsa Salehirad

Research output: Contribution to journal › Article › peer-review

Abstract

A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.

Original language	English (US)
Pages (from-to)	211-214
Number of pages	4
Journal	Journal of Advances in Medical and Biomedical Research
Volume	30
Issue number	140
DOIs	https://doi.org/10.30699/jambs.30.140.211
State	Published - May 1 2022
Externally published	Yes

All Science Journal Classification (ASJC) codes

Medicine(all)

Keywords

Anti-inflammatory
COVID-19
Plant-derived
Pulmonary fibrosis
TGF-β

Access to Document

10.30699/jambs.30.140.211

Cite this

@article{dca5b82c5f9342b69a9f0bf953a8633f,

title = "Standardized Herbal PM014 Formula Ameliorates Pulmonary Fibrosis in COVID-19 Patients by Inhibiting the TGF-β1 Signaling Pathway",

abstract = "A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.",

keywords = "Anti-inflammatory, COVID-19, Plant-derived, Pulmonary fibrosis, TGF-β",

author = "Maryam Allahverdi-Khani and Luis Ulloa and Majid Motaghinejad and Mahsa Salehirad",

year = "2022",

month = may,

day = "1",

doi = "10.30699/jambs.30.140.211",

language = "English (US)",

volume = "30",

pages = "211--214",

journal = "Journal of Advances in Medical and Biomedical Research",

issn = "1606-9366",

publisher = "Zanjan University of Medical Sciences and Health Services",

number = "140",

}

TY - JOUR

T1 - Standardized Herbal PM014 Formula Ameliorates Pulmonary Fibrosis in COVID-19 Patients by Inhibiting the TGF-β1 Signaling Pathway

AU - Allahverdi-Khani, Maryam

AU - Ulloa, Luis

AU - Motaghinejad, Majid

AU - Salehirad, Mahsa

PY - 2022/5/1

Y1 - 2022/5/1

N2 - A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.

AB - A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.

KW - Anti-inflammatory

KW - COVID-19

KW - Plant-derived

KW - Pulmonary fibrosis

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=85129204940&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85129204940&partnerID=8YFLogxK

U2 - 10.30699/jambs.30.140.211

DO - 10.30699/jambs.30.140.211

M3 - Article

AN - SCOPUS:85129204940

SN - 1606-9366

VL - 30

SP - 211

EP - 214

JO - Journal of Advances in Medical and Biomedical Research

JF - Journal of Advances in Medical and Biomedical Research

IS - 140

ER -

Standardized Herbal PM014 Formula Ameliorates Pulmonary Fibrosis in COVID-19 Patients by Inhibiting the TGF-β1 Signaling Pathway

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Access to Document

Other files and links

Fingerprint

Cite this